CWA Asset Management Group LLC Sells 765 Shares of HCA Healthcare, Inc. (NYSE:HCA)

CWA Asset Management Group LLC cut its position in HCA Healthcare, Inc. (NYSE:HCA) by 10.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 6,307 shares of the company’s stock after selling 765 shares during the period. CWA Asset Management Group LLC’s holdings in HCA Healthcare were worth $1,893,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently bought and sold shares of HCA. FMR LLC grew its position in shares of HCA Healthcare by 322.3% during the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after purchasing an additional 2,397,883 shares in the last quarter. Darsana Capital Partners LP lifted its holdings in shares of HCA Healthcare by 53.3% in the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after buying an additional 400,000 shares in the last quarter. Meritage Group LP bought a new stake in HCA Healthcare in the 3rd quarter valued at $150,548,000. Holocene Advisors LP lifted its position in shares of HCA Healthcare by 210.6% in the third quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock worth $124,691,000 after buying an additional 208,015 shares in the last quarter. Finally, Nordea Investment Management AB raised its holdings in shares of HCA Healthcare by 29.7% during the 4th quarter. Nordea Investment Management AB now owns 843,764 shares of the company’s stock worth $253,020,000 after acquiring an additional 193,075 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Insiders Place Their Bets

In other news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares of the company’s stock, valued at $18,445,700. This trade represents a 6.89 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.

HCA Healthcare Price Performance

Shares of HCA opened at $296.45 on Tuesday. The stock has a market capitalization of $75.09 billion, a PE ratio of 13.31, a PEG ratio of 1.21 and a beta of 1.64. HCA Healthcare, Inc. has a fifty-two week low of $276.50 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The company has a 50 day moving average price of $325.72 and a 200-day moving average price of $354.69.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.89%. The ex-dividend date of this dividend was Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.85%.

Analyst Ratings Changes

A number of research firms recently issued reports on HCA. KeyCorp decreased their price target on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $380.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 17th. TD Cowen decreased their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Morgan Stanley cut their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 17th. Finally, Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. One analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $388.60.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.